Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. - sprookjes - yvandenbroek - TriplyDB

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

http://www.wikidata.org/entity/Q34482745

about

HPV & head and neck cancer: a descriptive update Oral Leukoplakia as It Relates to HPV Infection: A Review Race as a social construct in head and neck cancer outcomes Oral cancer, HPV infection and evidence of sexual transmission The etiologic spectrum of head and neck squamous cell carcinoma in young patients The promise of immunotherapy in head and neck squamous cell carcinoma The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications Biomarkers of head and neck cancer, tools or a gordian knot?The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancer Lessons learned from next-generation sequencing in head and neck cancer An updated overview of HPV-associated head and neck carcinomas Human papilloma virus in head and neck cancers-role and relevance in clinical management Is radiation dose reduction the right answer for HPV-positive head and neck cancer?Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials.Human papillomavirus and gastrointestinal cancer: A review Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysis Aurora kinases in head and neck cancer Human papillomavirus-related esophageal cancer survival: A systematic review and meta-analysis Oral sex and oropharyngeal cancer: The role of the primary care physicians.NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study.Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome.Human Papilloma Virus (HPV) in head and neck region: review of literature.Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma.Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system.Integration of biomarkers including molecular targeted therapies in head and neck cancer.Clinical update on cancer: molecular oncology of head and neck cancer The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma.Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer.Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.

P2860

Q21198763-E4C3DC94-9AE7-4148-A19B-E0E8C2E7BF3E Q21285037-FB35EEC2-A57D-4281-BCA6-78474CEB4E97 Q24601617-548C18A7-7431-467C-9ED3-50C03BD73FE8 Q24617682-DEB18E9B-3556-47F8-BCDE-92BC46A7BB8E Q26741362-70D64C7F-A119-4EF8-A886-A2A2F3CEDE14 Q26744433-82718EBB-50A3-4FB1-AB52-A002F8BEBF58 Q26747516-7E2B45E8-9B22-4B50-A799-2C7BEBDE0AE5 Q26784289-29F65B6E-4ED0-4763-B68A-936B01D0727B Q26830495-867AD10C-FCCD-49E8-A8A9-1FBD3B8704A2 Q26852215-F11B0580-2CE9-43EC-A707-E8DFD854CBB7 Q27009148-228DFE68-BD04-4C58-AE99-92529700A109 Q27009209-128F95CF-22DD-4547-B3F5-0CDA106ECD93 Q27014019-B0DF7F24-1F2F-4C3C-8028-CC2132EFB33D Q27021230-90A2A3E5-B28C-4F09-B212-A8EE7C029C57 Q27024764-AF1B20ED-8DC1-4D95-ACD4-B4BD6041B70B Q27852908-FF42E534-1C2C-4411-9700-98A2509F318F Q27853003-FA56CD3C-21F4-4377-90E2-D88A4EB2A748 Q28069930-96EB86BB-4500-41F2-B43A-67C57D151C27 Q28386178-10DF33AD-3E0C-4760-8A57-FD4E3F1D11DE Q28654389-574CA071-5D34-42A0-AF39-EB1B3BFFEAA5 Q30241058-90446760-6DDF-4347-A7C7-4D93E607F737 Q30248928-498E22AC-F0BC-42EA-8F51-4796BA6EC5DE Q30300214-CFB922FF-90E5-49A2-9BE0-6EE9114D8034 Q30313175-DD860AF6-324A-4DEA-B463-F0BE98769FC2 Q31136389-2FD81E5B-004F-4E30-806B-AC5A417C070A Q33380006-B1BC722F-EDB0-4CC1-92E2-A34D8DD1E489 Q33570512-ABE1A786-0D3B-438D-81F5-F4E66ACC504F Q33610394-59A586E5-3226-4640-B565-8007E4912BE0 Q33611458-5E7C416B-9A22-48B4-9DFB-F58D14534C25 Q33626377-0CD31B5B-00DD-4FD0-AB8F-6E3B60AFBDD6 Q33671882-787D819F-0433-4A2A-84CF-613C1CF2A19B Q33674083-82186FD0-C339-46FE-AD68-658F6953FF45 Q33674090-74022746-AA29-4E5E-9432-8222EC55D546 Q33695197-39D9C049-C771-4FF5-95BF-E6924FFCFF86 Q33702362-B98D028E-B27C-4DC8-A56A-7EBF32CCBB55 Q33736889-F19391E9-AA6E-4BC9-82CB-73181969F6B5 Q33795763-5737BA2B-906F-48C1-A073-AE2C319A055B Q33798441-3B886F88-E795-491C-A604-F1CCBA7AE544 Q33805498-80F6C17B-0302-456D-9926-FF320D5D8CC8 Q33816576-69F230A1-09B3-46FB-980E-1D868B059BF8

P2860

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

http://www.wikidata.org/entity/Q34482745

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Molecular classification ident ...... cers with favorable prognosis.

@ast

Molecular classification ident ...... cers with favorable prognosis.

@en

Molecular classification ident ...... cers with favorable prognosis.

@nl

type

label

Molecular classification ident ...... cers with favorable prognosis.

@ast

Molecular classification ident ...... cers with favorable prognosis.

@en

Molecular classification ident ...... cers with favorable prognosis.

@nl

prefLabel

Molecular classification ident ...... cers with favorable prognosis.

@ast

Molecular classification ident ...... cers with favorable prognosis.

@en

Molecular classification ident ...... cers with favorable prognosis.

@nl

P1433

Q34482745-E57EEF7D-D175-417B-99F6-E7693CD4BDD3

P1476

Q34482745-C4563993-CF4F-44F3-AC4C-1D2A57D79BCA

P2093

Q34482745-115D4A41-855D-4108-B5CD-E217DC310EA5

Q34482745-22DC8F42-BEBC-4007-8F19-90E2338BDC5C

Q34482745-724B46A1-D6A6-471D-BE52-89DBA8C12C44

Q34482745-798FFD11-2EA1-4C78-BD6F-1669AF7B5504

Q34482745-9847CD28-1002-4479-B10D-638AC380A3FF

Q34482745-AB6D9FCC-E7AF-437D-BA92-DA81224F2E62

Q34482745-B9548A9D-B3EC-4753-9B76-2A473034F217

Q34482745-BD82303F-A2AE-4415-946A-F5D35351B269

Q34482745-C56AF442-52CB-40EC-86BA-990CF178AE27

Q34482745-D96DB8EE-9215-4742-BB1C-41B0BD990EAC

P304

Q34482745-42809791-D25E-4D44-A3C1-6EC736FDC14D

P31

Q34482745-B74FB755-8690-4E47-9F2B-1464366DF8FD

P356

Q34482745-5B6D5F88-D556-4DF9-954A-55A3A2B576C9

P407

Q34482745-6E521388-8524-4641-B463-046356D3902D

P433

Q34482745-A0D3E188-36EF-4490-9DF9-4CAF33AE7D44

P478

Q34482745-C391B07E-4CB5-4E36-ABAC-AFF9458A1D3C

P50

Q34482745-66E46AF8-07E8-4851-BE82-4062D9669D0E

P577

Q34482745-21CABBB9-8C5F-46E1-A36D-723910AF3785

P698

Q34482745-40E4C1BD-CD16-4FE6-9FBB-27ADCD41F2F7

P356

JCO.2004.00.3335

P1433

Journal of Clinical Oncology

P1476

Molecular classification ident ...... cers with favorable prognosis.

@en

P2093

Amanda Psyrri

http://www.w3.org/2001/XMLSchema#string

Bruce G Haffty

http://www.w3.org/2001/XMLSchema#string

Clarence Sasaki

http://www.w3.org/2001/XMLSchema#string

David L Rimm

http://www.w3.org/2001/XMLSchema#string

Diane Kowalski

http://www.w3.org/2001/XMLSchema#string

Janet Brandsma

http://www.w3.org/2001/XMLSchema#string

John Joe

http://www.w3.org/2001/XMLSchema#string

Malini Harigopal

http://www.w3.org/2001/XMLSchema#string

Robert L Camp

http://www.w3.org/2001/XMLSchema#string

Ziwei Yu

http://www.w3.org/2001/XMLSchema#string

P304

736-747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2004.00.3335

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Paul M. Weinberger

P577

2006-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16401683

http://www.w3.org/2001/XMLSchema#string